Clinical Trial Update: MLPR As A Diagnostic Marker For Acute Pulmonary Embolism

View source ↗

Summary

A completed clinical trial from Ain Shams University evaluated MLPR as a diagnostic biomarker for acute pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: Ain Shams University | Conditions: Pulmonary Embolism (Diagnosis), Diagnosis | Status: COMPLETED